Tandem Diabetes Care (Nasdaq:TNDM) announced that a study of adults with type 2 diabetes supported its automated insulin delivery system. The study evaluated adults with type 2 diabetes using the t:slim X2 insulin pump with Control-IQ technology. Patients achieved improvement in all clinical endpoints with the technology, which currently does not hold approval for type […]
Drug Pumps
Insulet warns of battery issues with some Omnipod Dash PDM devices
Insulet (Nasdaq:PODD) recently issued a voluntary global safety notice to warn of battery problems with its Omnipod Dash system. The Omnipod Dash is Insulet’s previous-generation insulin pump. The company since launched its FDA-cleared and CE-marked Omnipod 5 next-generation automated insulin delivery system. Insulet’s notice went out to current and past users of the Omnipod Dash […]
Insulet stock rises on Street-beating Q3, raised sales guidance
Insulet (Nasdaq:PODD) shares ticked up after hours today on third-quarter results that came in ahead of the consensus forecast. Shares of PODD rose 8.1% at $276 apiece after the market closed today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the day down 3.8%. The Acton, […]
Tandem stock dives on Q3 misses, reduced guidance
Tandem Diabetes Care (Nasdaq:TNDM) shares took a big hit after hours on third-quarter results that missed the consensus forecast. Shares of TNDM. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — closed the day down 0.3%. The San Diego-based company posted losses of nearly $49 million for the […]
Health Canada licenses Medtronic next-gen MiniMed 780G insulin pump
Medtronic (NYSE:MDT) Canada announced today that Health Canada granted a license to its MiniMed 780G automated insulin delivery system. The company designed its MiniMed 780G advanced hybrid closed-loop insulin pump system to automatically adjust and correct sugars every five minutes. According to Medtronic, it marks the first and only insulin pump system in Canada to […]
Here’s what diabetes tech companies are doing for National Diabetes Awareness Month
As we enter November, we enter National Diabetes Awareness Month. A number of diabetes technology developers plan to mark that in a special way. Dexcom (Nasdaq:DXCM), Insulet (Nasdaq:PODD) and Embecta (Nasdaq:EMBC) all announced their plans to celebrate. Last year, a handful of companies marked the month — which includes World Diabetes Day (Nov. 14) — […]
Baxter records $3.1B impairment over Hillrom acquisition
Baxter (NYSE:BAX) today posted third-quarter results that were in line with estimates on Wall Street, but it lowered its outlook for the remainder of the year amid macroeconomic headwinds. The Deerfield, Ill.–based company — maker of renal care products, drug delivery devices and more — also recorded impairment charges of $3.1 billion related to its […]
Insulet CEO Jim Hollingshead talks leadership in a time of change
Insulet (Nasdaq:PODD) CEO Jim Hollingshead says his current field in some ways marks his third different career path. He began as an academic, then went into consulting. The former ResMed executive took over in the corner office at Insulet following CEO Shacey Petrovic’s departure for personal reasons earlier this year. He’s served on Insulet’s board since […]
Medtronic launches diabetes insights program for MiniMed users
Medtronic (NYSE:MDT) announced today that it introduced a new diabetes management program for users of the MiniMed 770G insulin pump. The medtech giant calls the new program My Insights. It designed it exclusively for individuals using the MiniMed 770G hybrid closed-loop insulin delivery system. Get the full story at our sister site, Drug Delivery Business […]
Koru Medical appoints new VP of medical affairs
Koru Medical Systems (Nasdaq:KRMD) announced today that it appointed Brent Rutland as its new VP of medical affairs. Rutland joins the Mahwah, New Jersey-based drug delivery technology developer with 27 years of experience in the space. Most recently, he served as a senior director for health outcomes at La Jolla Pharmaceutical Company. Get the full […]
Iradimed withdraws 510(k) application for MR-compatible IV pump
Iradimed (Nasadq:IRMD) announced that it voluntarily withdrew an FDA 510(k) application for its new model MR IV pump. Winter Springs, Florida-based Iradimed said it learned that the FDA likely wouldn’t have time to finish clearance activities for the pending submission. Upon learning this, the company decided to voluntarily withdraw its application on Oct. 5. The […]